Correlation Between Milestone Pharmaceuticals and Histogen
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Histogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Histogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Histogen, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Histogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Histogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Histogen.
Diversification Opportunities for Milestone Pharmaceuticals and Histogen
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and Histogen is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Histogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Histogen and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Histogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Histogen has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Histogen go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Histogen
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.22 times more return on investment than Histogen. However, Milestone Pharmaceuticals is 4.46 times less risky than Histogen. It trades about 0.36 of its potential returns per unit of risk. Histogen is currently generating about -0.24 per unit of risk. If you would invest 145.00 in Milestone Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 54.00 from holding Milestone Pharmaceuticals or generate 37.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Histogen
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Histogen |
Milestone Pharmaceuticals and Histogen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Histogen
The main advantage of trading using opposite Milestone Pharmaceuticals and Histogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Histogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will offset losses from the drop in Histogen's long position.The idea behind Milestone Pharmaceuticals and Histogen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Histogen vs. Virax Biolabs Group | Histogen vs. Altamira Therapeutics | Histogen vs. Aileron Therapeutics | Histogen vs. Artelo Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |